Altimmune (ALT) Shares Outstanding (Diluted) (2014 - 2026)

Altimmune (ALT) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Altimmune 571.75 Mn 571.75 Mn - 185.44 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 124.46 Mn
Mar 31, 2026 124.46 Mn
Dec 31, 2025 88.10 Mn
Sep 30, 2025 89.42 Mn
Jun 30, 2025 81.48 Mn
Mar 31, 2025 75.55 Mn
Dec 31, 2024 71.00 Mn
Sep 30, 2024 71.08 Mn
Jun 30, 2024 70.92 Mn
Mar 31, 2024 70.80 Mn
Dec 31, 2023 53.25 Mn
Sep 30, 2023 53.63 Mn
Jun 30, 2023 50.69 Mn
Mar 31, 2023 50.13 Mn
Dec 31, 2022 46.93 Mn
Sep 30, 2022 49.29 Mn
Jun 30, 2022 47.50 Mn
Mar 31, 2022 43.97 Mn
Dec 31, 2021 41.28 Mn
Sep 30, 2021 41.37 Mn